Mineralys Therapeutics, Inc. (MLYS)

25.89 +0.62 (+2.45%) USD  |  NASDAQ  |  Aug 25, 10:05
More

Mineralys Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for MLYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to 2025. Start Trial.
Date Value
December 31, 2025 --

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
MapLight Therapeutics, Inc. --
Evommune, Inc. --
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Sangamo Therapeutics, Inc. Upgrade